Ravulizumab - Alexion AstraZeneca Rare Disease
At a glance
- Drug Originator Alexion Pharmaceuticals
- Drug Class Anti-inflammatories; Antithrombotics; Eye disorder therapies; Monoclonal antibodies; Urologics
- Mechanism of Action Complement C5 inhibitors
- USA Patent Applicants ALEXION PHARM
- USA Patents 9
- BLAs 1
- International Patents 97

Disclaimer